Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (13330)	1/15/1998 8:48:00 AM
From: CYBERKEN	Read Replies (1) \| Respond to of 32384

My position is that whoever was the toughest at the table a year ago, the "other guy" made a big mistake not wrapping up an alliance with Ligand much earlier, since Ligand has more and more leverage as time passes. Robinson probably is much more patient than me (fortunately for all of us shareholders), because I definitely would have walked away from this unfinished deal the day we got Lilly. As it is, if a Leptin deal is finally signed with this partner, I will continue to be skeptical of the partnership, and would not be surprised to see it eventually end unsatisfactorily for both companies. Of course, DR probably has his strategy all worked out exclusive of my advice. (:->)